Larry Gold, PhD

Larry Gold is the founder and chairman of the board, and past CEO of SomaLogic. Prior to SomaLogic, he founded NeXagen, Inc., which later became NeXstar Pharmaceuticals, Inc. In 1999, NeXstar merged with Gilead Sciences, Inc. to form a global organization committed to the discovery, development, and commercialization of novel products that treat infectious diseases.

During nearly 10 years at NeXstar, Dr. Gold held numerous executive positions including chairman of the board, executive vice president of R&D, and chief science officer. Before forming NeXagen, he also co-founded and served as co-director of research at Synergen, Inc., a pioneering biotechnology company later acquired by Amgen, Inc. Since 1970, Dr. Gold has been a professor at the University of Colorado Boulder. He served as the chairman of the molecular, cellular, and developmental biology department from 1988 to 1992.

Dr. Gold received the CU Distinguished Lectureship Award, an NIH Merit Award, a Career Development Award, and the Chiron Prize for Biotechnology. In addition, Dr. Gold has been a member of the American Academy of Arts and Sciences since 1993 and the National Academy of Sciences since 1995.

Dr. Gold also serves on the board of directors of CompleGen and Plato BioPharma, and is a member of the Institute for Genome Biology External Advisory Board at the University of Illinois at Urbana-Champaign.